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Abstract
Background: Mycobacterium avium are ubiquitous environmental organisms and a cause of disseminated
infection in patients with end-stage AIDS. The glycopeptidolipids (GPL) of M. avium are proposed to
participate in the pathogenesis of this organism, however, establishment of a clear role for GPL in disease
production has been limited by the inability to genetically manipulate M. avium.
Methods: To be able to study the role of the GPL in M. avium pathogenesis, a ts-sacB selection system,
not previously used in M. avium, was employed as a means to achieve homologous recombination for the
rhamnosyltransferase (rtfA) gene of a pathogenic serovar 8 strain of M. avium to prevent addition of
serovar-specific sugars to rhamnose of the fatty acyl-peptide backbone of GPL. The genotype of the
resultant rtfA mutant was confirmed by polymerase chain reaction and southern hybridization. Disruption
in the proximal sugar of the haptenic oligosaccharide resulted in the loss of serovar specific GPL with no
change in the pattern of non-serovar specific GPL moieties as shown by thin layer chromatography and
gas chromatography/mass spectrometry. Complementation of wild type (wt) rtfA in trans through an
integrative plasmid restored serovar-8 specific GPL expression identical to wt serovar 8 parent strain.
Results: In this study, we affirm our results that rtfA encodes an enzyme responsible for the transfer of
Rha to 6d-Tal and provide evidence of a second allelic exchange mutagenesis system suitable for M. avium.
Conclusion: We report the second allelic exchange system for M. avium utilizing ts-sacB as double-
negative and xylE as positive counter-selection markers, respectively. This system of allelic exchange would
be especially useful for M. avium strains that demonstrate significant isoniazid (INH) resistance despite
transformation with katG. Through the construction of mutants in GPL or other mycobacterial
components, their roles in M. avium pathogenesis, biosynthesis, or drug resistance can be studied in a
consistent manner.
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Background
Mycobacterium avium is a frequent cause of disseminated
infection among patients with end-stage AIDS [9,11,19].
M. avium can also present with a similar spectrum of pul-
monary and extra pulmonary syndromes as Mycobacterium
tuberculosis  [27] including the establishment of latent
infection that can reactivate concomitant with immune
suppression [13]. While significant advances have been
made in deciphering the host responses against M. avium
infection, there is only a rudimentary understanding of
the bacterial factors involved in the pathogenesis of infec-
tion [14,22].
Numerous studies have implicated the cell wall lipids in
mycobacterial pathogenesis. For M. avium, there is evi-
dence that the glycopeptidolipids (GPL), as the dominant
lipid for this species, may negatively affect host immunity
[4,25]. Study of GPL in M. avium pathogenesis has been
limited by a lack of suitable genetic techniques to be able
to create site directed knockouts. Further, as reviewed
below, there is controversy as to which portion of GPL
predominates in disease production.
The GPLs are comprised of a lipopeptide (LP) core of D-
phenylalanine-D-allo  threonine-D-alanine-alaninol with
a fatty acyl group N-linked to the phenylalanine residue
and a methylated rhamnose modifying the terminal alani-
nol. The LP core is glycosylated at D-allo threonine with 6-
deoxytalose (6dTal) to form non-specific GPL (nsGPL)
and is further glycosylated at 6dTal with a haptenic oli-
gosaccharide to yield serovar-specific GPL (ssGPL). All
serovars maintain a common α-L-rhamnopyranosyl-
(1→2)-6dTal [6].
Historically, the predominance of serovars 1, 4, and 8,
among patients with disseminated infection [10,26] has
been suggested as evidence to support a role for the oli-
gosaccharide moiety of GPL in pathogenesis, but may
conversely represent the fact that a restricted set of clones
are disease producing. More direct evidence of a role of
the GPL oligosaccharide in pathogenesis is provided by
the study of Minami that demonstrated that heat-killed
Staphylococcus aureus coated with M. avium GPL promote
phagocytosis and inhibit phagolysosomal fusion in rela-
tion to serovar [17]. Other studies have, however, sug-
gested a dominant role for the lipopeptide core in
pathogenesis [5]. Significantly limiting the development
of a consistent framework of the role of GPL in mycobac-
terial pathogenesis has been the inability to construct iso-
genic strains differing in GPL structure, necessitating the
comparison of genetically distinct strains of differing
serotypes.
To study the role of the serovar-specific oligosaccharide
moiety of GPL in the pathogenesis of M. avium, an allelic
exchange mutant in rtfA was created for a pathogenic sero-
var 8 strain to yield a strain deficient in ssGPL. Homolo-
gous recombination was performed using a novel allelic
exchange vector that incorporated a temperature-sensitive
mycobacterial origin of replication (ts-oriM) and sacB as
counter selective markers [21] and xylE [7] as a positive
selection marker. Complementation of rtfA  in  trans
through an integrative plasmid restored serovar-8 specific
GPL expression identical to wild type (wt) serovar 8
smooth opaque (SmO) parent strain. In addition to reaf-
firming our results for serovar 2 [15] that rtfA encodes an
enzyme responsible only for the transfer of Rha to 6d-Tal
to form the serovar-8 specific oligosaccharide, this study
delineates a second system of allelic exchange mutagene-
sis for M. avium.
Methods
Bacterial strains and plasmids
Escherichia coli strain DH5α was used as the host strain for
plasmid construction and propagation. Wild type and
recombinant  M. avium and  Mycobacterium smegmatis
strains were grown in Middlebrook 7H9 broth or 7H11
agar supplemented with 10% OADC (Difco Laboratories,
Detroit, MI) at 37°C, except where indicated. M. smegma-
tis mc2155 [24] was employed as a test strain for mycobac-
terial shuttle vectors. M. avium 920A6 is a serovar 8
bloodstream isolate cultured from a patient with AIDS
[1]. Transformation of E. coli and M. smegmatis was per-
formed as described [23,24]. Transformation of M. avium
was performed according to the protocol of Lee et al. [12].
For E. coli, selection was carried out using ampicillin at 50
µg ml-1 and kanamycin at 25 µg ml-1. For M. smegmatis
and M. avium, selection was accomplished using hygro-
mycin at 100 µg ml-1, gentamicin at 100 µg ml-1, and kan-
amycin at 50 µg ml-1.
Construction of allelic exchange vector pVAP39
The allelic exchange vector pVAP39 was created in a man-
ner similar to allelic exchange vector pVAP41 [15] to
include counter selection markers ts-oriM, sacB, and the
hygromycin resistance gene (hyg); and positive selection
marker  xylE. Construction of allelic exchange vector
pVAP39 is shown in Fig. 1. The 1.1 kb BamHI-XbaI frag-
ment of pXYL4 containing the xylE gene [21] was ligated
into the BamHI site of pPR27, containing a temperature-
sensitive origin of replication of M. fortuitum plasmid
pAL5000 and sacB [21] to create pVAP38 (10.8 kb). The
3.2 kb XbaI-XhoI fragment containing rtfA::hyg, isolated
from pVAP37 [15], was blunt-ligated into pVAP38 to cre-
ate pVAP39 (14.1 kb). The presence of rtfA::hyg in pVAP38
was confirmed by PCR and Southern blot analysis as
described [15]. Expression of XylE was detected by apply-
ing one drop of filter-sterilized 1.1% catechol solution
(1.1% catechol in 50 mM potassium phosphate buffer,
pH 7.5) to individual colonies to detect a yellow colorAnnals of Clinical Microbiology and Antimicrobials 2004, 3:18 http://www.ann-clinmicrob.com/content/3/1/18
Page 3 of 9
(page number not for citation purposes)
Construction of allelic exchange vector pVAP39 Figure 1
Construction of allelic exchange vector pVAP39. See Methods and Reference 15 for details.Annals of Clinical Microbiology and Antimicrobials 2004, 3:18 http://www.ann-clinmicrob.com/content/3/1/18
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[20]. Plasmid pVAP42 was constructed by ligating the
amplified wt rtfA gene with HindIII overhangs into the
HindIII  site of plasmid pMVGFP (kanamycin-resistant,
GFP-positive, [12]). Plasmid pVAP52 was constructed by
ligating the amplified wt rtfA gene with HindIII overhangs
into the HindIII site of plasmid pIGFP2 (kanamycin-resist-
ant, GFP-positive, [12]).
Isolation and analysis of GPL
Colonies of wt, mutant, and complemented strains were
collected from 7H10 plates. Procedures for purification of
alkaline stable GPLs, and alditol acetate analyses of sugar
moieties by gas chromatography/mass spectrometry (GC/
MS) were performed as described by Eckstein et al [8].
Results
Selection of rtfA allelic exchange mutants of M. avium 
920A6 strain
The expression of xylE was first examined for M. avium
since there is minimal published data on the use of this
marker in mycobacteria. After construction, pVAP38 was
first electroporated into M. smegmatis strain mc2155 to
assess expression in a test system. All (100%) of gen-
tamicin-resistant colonies expressed XylE as determined
by a yellow color change after application of catechol. M.
avium 920A6 SmO was then transformed with pVAP39
and selected at 32°C on 7H11 medium containing 100 µg
ml-1 hygromycin. Yellow colonies were easily detected,
indicating that xylE represents a suitable marker for M.
avium. However, only 25–40% of hygromycin-resistant
colonies yielded a yellow color, indicating a high rate of
spontaneous hygromycin resistance when M. avium is
transformed at 32°C, with a final efficiency of transforma-
tion of 1–8 × 102 transformants per µg of DNA. These
results contrasted with our earlier observations that trans-
formation of M. avium with non-temperature sensitive
plasmids yielded less than 5% of spontaneously resistant
colonies and an efficiency of transformation 1.6-log
higher (8 × 103 transformants per µg of DNA, [12]).
To derive an allelic exchange mutant, a representative
hygromycin-resistant, XylE-positive colony of M. avium
920A6 SmO/pVAP39 was inoculated into 7H9 medium
for 3 weeks at 32°C to late log phase. Growth in hygromy-
cin-free medium allowed for spontaneous loss of plasmid
DNA. Moreover, expansion in hygromycin-free medium
limited the appearance of spontaneous hygromycin resist-
ance (unpublished data). Selection for allelic exchange
mutants was performed at 39°C on 7H11 medium con-
taining 100 µg ml-1 hygromycin and 2% (w/v) sucrose to
isolate single colonies. Incubation at 39°C precludes the
replication of the temperature-sensitive origin of replica-
tion of pVAP39. Hygromycin-resistant, XylE-positive col-
onies that arose at this non-permissive temperature
represented single crossover mutants or illegitimate
recombinants, whereas XylE-negative colonies repre-
sented either double crossover mutants or colonies that
had lost plasmid DNA and had developed spontaneous
hygromycin resistance. Growth on sucrose was used as a
means to eliminate strains that retained plasmid DNA.
Of >104 colonies screened, three XylE-negative colonies
were identified of which only one (213R.4) colony with
an SmO morphotype yielded a single 3.2 kb PCR product
corresponding to the 1.9 kb rtfA gene interrupted with the
1.3 kb hyg cassette. Southern blot analysis confirmed that
strain 213R.4 possessed only a chromosomal copy of
rtfA::hyg (Fig 2a,2b). The remaining 2 XylE-negative colo-
nies yielded a single 1.9 kb band corresponding to the
native  rtfA  gene, indicating spontaneous hygromycin-
resistant strains.
GPL analysis of serovar 8 M. avium strains by TLC and GC-
MS
Total lipids were isolated from wild type and mutant
strains. Alkaline stable lipids analyzed by TLC demon-
strated that wt strains 920A6 SmO and 920A6 SmT
expressed serovar 8 specific GPL (Fig. 3, lanes 1, 2). Strain
213R.4 was devoid of ssGPL but produced an identical
pattern of nsGPL as the wt strains (Fig. 3, lane 3). To con-
firm that the loss of serovar 8 specific GPL resulted from
the disruption of rtfA, clone 213R.4 was transformed with
integrative (pVAP52) plasmid to complement rtfA  in
trans. Strain 233R.1 created by transformation of 213R.4
with pVAP52 and thus containing only a single copy of
rtfA, demonstrated a pattern of ssGPL and nsGPL similar
to wild-type, serovar 8 M. avium (Fig. 3, lane 5). Strain
277R.1 created by transformation of 213R.4 with rtfA on
an episomal plasmid (pVAP42) expressed ssGPL but not
nsGPL (Fig. 3. lane 4).
Analysis of the glycosyl residues was performed by GC-MS
of alditol acetate derivatives of GPL (Fig. 4). Relative to wt
920A6 SmO (Fig. 4, panel B), clone 213R.4 (Fig. 4, panel
A) demonstrated loss of both the non-methylated rham-
nose (Rha) of the haptenic oligosaccharide (peak 4) and
the terminal glucose residue (peak 6). Clone 213R.4 how-
ever retained 3,4-O-diMe-Rha (peak 1), 3-O-Me-6dTal
(peak 2), 3-O-Me-Rha (peak 3), and 6dTal (peak 5) asso-
ciated with nsGPL. Individual nsGPL and ssGPL band(s)
were isolated from a preparative TLC gel and each band
resolved separately by TLC (Fig. 5) and analyzed by GC.
Band α, absent from 213R.4, contained serovar 8 specific
GPL. Bands β, γ2, γ3, and δ represented nsGPL bands dem-
onstrating the sequential addition of methyl groups to
Rha attached to the alaninol of the nsGPL, and 6dTal to
generate serovar 8 specific GPL (band α). These data fur-
ther confirm our previous results for serovar 2 [15] that
rtfA  encodes for the transfer of Rha to 6dTal as the
proximal sugar in the oligosaccharide moiety of GPL andAnnals of Clinical Microbiology and Antimicrobials 2004, 3:18 http://www.ann-clinmicrob.com/content/3/1/18
Page 5 of 9
(page number not for citation purposes)
does not encode for the transfer of Rha to the alaninol of
the GPL lipopeptide core.
Discussion
Here we report on the generation of allelic exchange
mutants using a double negative-selection system utiliz-
ing a temperature sensitive origin of replication of plas-
mid pAL5000 and the Bacillus subtilis sacB gene. This
vector (pPR27) has been used successfully to generate
homologous recombinants of M. tuberculosis [21]. The
inclusion of the reporter gene xylE [7], that encodes for
catechol 2,3-dioxygenase and converts catechol into 2-
hydroxymuconic semialdehyde [20], provided identifica-
tion of true transformants and allowed for differentiation
of putative double crossover mutants (XylE-negative)
from single crossover mutants or illegitimate recom-
binants (XylE-positive).
We observed a high background of hygromycin-resistant,
sucrose-resistant, XylE-positive colonies after selection at
39°C on sucrose-containing media suggesting a high fre-
quency of a single crossover or illegitimate recombina-
tion. The high number of XylE-positive clones either
represented a high degree of spontaneous mutation in
sacB or the inability of this gene to provide efficient coun-
ter selection as a single copy. The latter was consistent
with our observation that katG expressed as a single copy-
integrant did not confer INH-susceptibility to M. avium
sufficient to serve as a counter selection marker [15].
Additionally, we observed a high degree of spontaneous
hygromycin resistance at 32°C. Although poorly efficient,
this system of allelic exchange would be useful for strains
that exhibit significant isoniazid resistance despite trans-
formation with katG, as we have observed with the
smooth transparent (SmT) morphotype of 920A6
(unpublished data). In this system, for INH-resistant
strains, it may be prudent to perform selections as a two-
step process, i.e., growth in broth at 39°C to eliminate
plasmid replication followed by selection in solid
medium containing hygromycin to increase the yield of
double crossover mutants in relation to spontaneous
hygromycin-resistant strains. Although sacB  is a useful
marker for M. tuberculosis, it appears to be minimally use-
ful as a counter-selection marker for allelic exchange in M.
avium. Also, this is the first reported instance of using xylE
as a marker for allelic exchange in M. avium.
The glycopeptidolipids represent the most abundant cell
wall component of M. avium. Studies have suggested a
role for serovar-specific GPL in the pathogenesis of M.
avium  infection as highly antigenic molecules [16]
affecting host immune function. However, these data
PCR and Southern hybridization of wild type 920A6 and ∆rtfA mutant, 213R.4 Figure 2
PCR and Southern hybridization of wild type 920A6 and ∆rtfA mutant, 213R.4. (A) PCR of wild type M. avium 920A-6 (lane 3) 
yielded a single 1.9 kb band corresponding rtfA whereas the rtfA mutant 213R.4 yielded a 3.2 kb band corresponding to rtfA with 
an inserted 1.3 kb hygromycin resistance gene cassette (rtfA::hyg, lane 2). Vector pVAP39 served as a positive control (lane 4). 
Lane 1 represents a molecular weight marker. (B) Southern blot analysis of genomic DNA from wt M. avium 920A6 and clone 
213R.4 was digested with HindIII and probed for rtfA. M. avium 920A6 yielded a 11.13 kb band (lane 2) whereas clone 213R.4 
(lane 1) yielded a 12.49 kb band, corresponding to the incorporation of the 1.3 kb hyg gene.
AB
1     2     3    4  1            2
3.2kb
1.9kb
12.49 kb
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have relied on comparisons of strains representing differ-
ent serovars [18] or have used purified and/or chemically
modified GPL and GPL components [2,3,5,25]. In this
study, we disrupted the rtfA gene via homologous recom-
bination to block the addition of rhamnose as the proxi-
mal sugar common to ssGPLs resulting in construction of
isogenic mutants expressing only non-specific GPL. Com-
plementation of the rtfA gene as a single copy integrant in
trans restored ssGPL synthesis and maintained nsGPL syn-
thesis. Complementation of the ssGPL-null mutant with
rtfA on an episomal plasmid, however yielded only sero-
var-8 specific GPL. In the latter case, all nsGPL compo-
nents (bands β, γ2, γ3, δ) were utilized as substrates for
generation of ssGPL and thus were lost due to over-expres-
sion of rtfA. Also, since we do not observe any serovar-1
ssGPL (6dTal-Rha) on TLC or GC analyses, this would
Thin layer chromatography (TLC) of alkaline-stable lipids from GPL mutants of 920A6 Figure 3
Thin layer chromatography (TLC) of alkaline-stable lipids from GPL mutants of 920A6. GPL were isolated from each strain and 
100 µg of lipid was applied to each lane on a silica gel TLC plate, developed in CHCl3:CH3OH:H2O (65:35:4), and sprayed with 
H2SO4 in ethanol. Lane 1, 920A6 SmO; Lane 2, 920A6 SmT; Lane 3, ∆rtfA mutant 213R.4; Lane 4, 227R.1; Lane 5, 233R.1. Wild-
type strains 920A6 SmT and 920A6 SmO both expressed ssGPL and nsGPL whereas 213R.4 did not express serovar-8 specific 
GPL (arrow). Complementation of rtfA with a single copy integrant restored ssGPL expression for 233R.1 to a pattern similar 
to wild-type M. avium. Strain 227R.1 complemented with rtfA on an episomal plasmid expressed ssGPL but did not express 
nsGPL.
non-specific GPLs
ser8 specific GPL
1            2              3               4             5Annals of Clinical Microbiology and Antimicrobials 2004, 3:18 http://www.ann-clinmicrob.com/content/3/1/18
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suggest that the serovar-8 specific GPL disaccharide Rha-
Gluc was generated prior to its addition to 6dTal for the
generation of ssGPL.
Conclusion
Insertion mutagenesis via the ts-sacB double negative and
xylE counter-selection system was reported for M. avium
and we were able to construct isogenic mutants devoid of
serovar-8 GPL. Due to limitations of various genetic
manipulation techniques, this is the second only reported
allelic exchange system for M. avium. With a few experi-
mental modifications, this system of allelic exchange
would be especially useful for M. avium strains that dem-
onstrate high levels of INH drug resistance. Finally,
through the construction of mutants in GPL (or any other
cellular component) synthesis, the role of M. avium GPLs
(and other components) in host-pathogen interaction,
immunogenesis, and other qualities such as drug resist-
ance can be determined.
List of abbreviations used
GPL: glycopeptidolipid
6-d Tal: 6-deoxytalose
nsGPL: non-specific glyopeptidolipid
ssGPL: serovar-specific glycopeptidolipid
rtfA: rhamnosyltransferase
wt: wild type
LP: lipopeptide
SmO: smooth opaque
Rha: rhamnose
Hyg: hygromycin
GC/MS: gas chromatography/mass spectrometry
PCR: polymerase chain reaction
TLC: thin-layer chromatography
3,4-O-diMe-Rha: 3,4-O-dimethyl-Rhamnose
3-O-Me-6dTal: 3-O-Methyl-6-deoxytalose
3-O-Me-Rha: 3-O-Methyl-Rhamnose
SmT: smooth transparent
INH: isoniazid hydrazide
6dTal-Rha: 6-deoxytalose-rhamnose
Rha-Gluc: rhamnose-glucose
µg ml-1: microgram per milliliter
Gas chromatography of alditol derivatives of GPL of 920A6  SmO and ∆rtfA mutant 213R.4 Figure 4
Gas chromatography of alditol derivatives of GPL of 920A6 
SmO and ∆rtfA mutant 213R.4. Panel A, 213R.4; Panel B, 
920A6 SmO, Panel C rhamnose (Rha) standard. Peaks 1, 2, 3, 
4, 5 and 6 represent 3,4-O-dimethylrhamnose (diMe-Rha), 3-
O-methyl-6dtalose (3-O-Me-6dTal), 3-O-methylrhamnose 
(Me-Rha), rhamnose (Rha), 6dTal, and glucose, respectively. 
The peak at 18.5 min. in all the panels represents the Rha 
standard. Peaks with asterisks (*) do not represent pattern 
associated with alditol acetates of known sugars.Annals of Clinical Microbiology and Antimicrobials 2004, 3:18 http://www.ann-clinmicrob.com/content/3/1/18
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